Pricing Pharmaceuticals: Value Based Pricing in What Sense?
(2008; 4 pages)

Abstract

Reimbursement of pharmaceuticals ought to provide both incentives for and reward innovation, as well as set a price which reflects the market value of the product. In other words reimbursement must reward both dynamic and static efficiency in the pharmaceutical sector. Within the UK a debate has emerged concerning whether the Pharmaceutical Pricing and Reimbursement Scheme, a profits based regulatory scheme, should be replaced with a value based pricing scheme. This article defines these competing reimbursement schemes and outlines their relative costs and benefits.

 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014